Structural process and implementation programs of pharmaceutical care in different countries

Current Pharmaceutical Design

Volumn 10, Issue 31, 2004, Pages 3969-3985

  Martin Calero M J ^a   Machuca, M ^a   Murillo, M D ^a   Cansino, J ^a   Gastelurrutia, M A ^b   Faus, M J ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PHARMACY; COOPERATION; DOCTOR PATIENT RELATION; DRUG SURVEILLANCE PROGRAM; EDUCATION PROGRAM; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INTERPERSONAL COMMUNICATION; INTERVIEW; MEDICAL DOCUMENTATION; MEDICAL EDUCATION; METHODOLOGY; OUTCOMES RESEARCH; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; POSTGRADUATE EDUCATION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; RESPONSIBILITY; REVIEW; UNITED STATES;

DELIVERY OF HEALTH CARE; DRUG THERAPY; HUMANS; INTERNATIONALITY; INTERPROFESSIONAL RELATIONS; MEDICAL RECORDS; PATIENT CARE TEAM; PHARMACEUTICAL SERVICES; SOCIETIES, PHARMACEUTICAL;

EID: 9944254633     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043382549     Document Type: Review

References (177)

1. Hepler CD, Strand LM. Opportunities and responsibilities in Pharmaceutical Care. Am J Hosp Pharm 1990; 47: 533-43.
2. Mikeal RL, Brown TR, Lazarus HL, Vinson C. Quality of pharmaceutical care in hospitals. Am J Hosp Pharm 1975; 32: 567-74
3. Brodie DC. Drug Use Control: keystone to pharmaceutical service. Drug Intell Clin Pharm 1967; 1: 63-5.
4. Brodie DC. Pharmacy's societal purpose. Am J Hosp Pharm 1981; 38: 1893-986.
5. Hatoum HT, Catizone C, Hutchinson RA, Purohit A. An eleven-year review of the pharmacy literature: documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm 1986; 20: 33-48.
6. Hepler CD. Pharmacy as a clinical profession. Am J Hosp Pharm 1985; 42: 1298-306.
7. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice. Minneapolis: McGraw- Hill; 1998.
8. Winsdale NE, Strand LM, Pugsley JA, Perrier DG. Practice functions necessary for the delivery of pharmaceutical care. Pharmacotherapy 1996; 16: 889-98.
9. Roughead L, Semple S, Vitry A. The value of Pharmacist Proffesional Services in the community setting. A systematic review of the literature 1990-2002. Adelaide: University South of Australia; 2002.
10. Barber N. Pharmaceutical care and medicines management, is there a difference? Pharm World Sci 2001; 23: 205-9.
11. Benrimoj SI, Langford JH, Berry G, Collins D, Lauchlan R, Stewart K, et al. Economic impact of increased clinical intervention rates in community pharmacy. A randomised trial of the effect of education and a professional allowance. Pharmacoeconomics 2000; 18: 459-68.
12. Chen TF, Crampton M, Krass I, Benrimoj SI. Collaboration between community pharmacists and GPs - the medication review process. J Suc Adm Pharm 1999; 16: 145-156.
13. Hen T, Whitehead P, Williams K, Moles R, Aslani P, Benrimoj SI. Case studies in practice. Medication Review: a process guide for pharmacists. 2002 Pharmaceutical Society of Australia.
14. Roberts AS, Hopp T, Sørensen EW, Benrimoj SI, Chen TF, Herborg H, et al. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci 2003; 25: 227-34.
15. The Pharmacy Practice Activity Classification. http://www.aphanet.org/ (accessed 03/04/2004).
16. Consensus Committee. Consensus on Pharmaceutical Care. Ars Pharmaceutica 2002; 42: 221-41.
17. Johnson JA, Bootman JL. Drug- related morbidity and mortality. Arch Intern Med 1995; 155: 1949-56.
18. Johnson JA, Bootman JL. Drug- related morbidity and mortality and the economic impact of Pharmaceutical Care. Am J Health Syst Pharm 1997; 54: 554-8.
19. Faus MJ, Martínez- Romero F. Pharmaceutical Care in community pharmacies: evolution of the concept, training requirements, modalities and implementation strategies. Pharm Care Esp 1999; 1: 52-61.
20. Beney J, Bero LA, Bond C. Expanding the roles of outpatiens pharmacists: effects on health services utilisation, costs and patiens outcomes (Cochrane Review). The Cochrane Library, Issue 3, 2002. Oxford: Update Software.
21. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP Ann Pharmacother 1990; 24: 1093-97.
22. Summers R. Pharmaceutical Care: a planned approach. Aus J Hosp Pharm 1996; 26: 37-9.
23. Machuca M, Fernández- Llimós F, Faus MJ. Dader Method of Drug- therapy Follow- up. Granada: GIAF; 2003.
24. Snella KA, Sachdev GP. A primer for developing pharmacist-managed clinics in the outpatient setting. Pharmacotherapy 2003; 23: 1153-66.
25. McDonough RP, Pithan ES, Doucette WR. Brownlee MJ. Marketing Pharmaceutical Care Services. J Am Pharm Assoc 1998; 38: 667-81.
26. Penna RP. Pharmaceutical care: Pharmacy's mission for the 1990s. Am J Hosp Pharm 1990; 47: 543-49.
27. McDonough RP. Interventions to improve patient pharmaceutical care outcomes. J Am Pharm Assoc 1996; 36: 453-65.
28. Kassam R, Farris KB, Cox C, Volume CI, Cave A, Schopflocher DP, et al. Tools used to help community pharmacists implement Comprehensive Pharmaceutical Care. J Am Pharm Assoc 1999; 39: 843-56.
29. Caelles N, Ibañez J, Machuca M, Martinez- Romero F, Faus MJ. Pharmacist- patient interview in the Dader Program of Pharmaceutical Care. Pharm Care Esp 2002; 4: 55-9.
30. Ellington AM, Barnett CW, Jonson DR, Nykamp D. Current methods used to teach the medication history interview to Doctor of Pharmacy students. Am J Pharm Educ 2002; 66:103-7.
31. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsan GD. Drug-related problems: their structure and function. Ann Pharmacother 1990; 24: 1093-7.
32. Westerlund T, Almarsdottir AB, Melander A. Factors influencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci 1999; 21: 245-50.
33. Shaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-doc. Pharm Word Sci 2002; 24: 120-7.
34. American Society of Health-System Pharmacists. ASHP guidelines on a standardized method for pharmaceutical care. Am J Health-Syst Pharm 1996; 53: 1713-6.
35. Smith CP, Christensen DB. Identification and clarification of drug therapy problems by Indian Health Service pharmacists. Ann Pharmacother 1996; 30: 119-24.
36. Consensus Committee. Second Consensus of Granada on Drug Therapy Problems. Ars Pharmaceutica 2002; 43:179-87.
37. Machuca M, Oñate MB, Faus MJ. Drug-related problems: DRP and risk of DRP. Seguim Farmacoter 2003; 1: 139-40.
38. Morrow NC, D'Arcy PF, Pielow LW. Drug information inquiries - who asks, what and where are the answers?. J Clin Hosp Pharm 1984; 9:321-31.
39. Cardoni AA. Drug information centers: meeting future needs for drug information. Am J Hosp Pharm 1983; 40: 1215-7.
40. Calis KA, Anderson DW, Auth DA, Mays DA, Turcasso NM, Meyer CC, et al. Quality of pharmacotherapy consultations provided by drug information centers in the USA. Pharmacotherapy 2000; 20: 830-6.
41. Davidoff F, Florance V. The informationist: a new health profession?. Ann Intern Med 2000; 132: 996-8.
42. Byrd GD. Can the profession of pharmacy serve as a model for health informationist professionals?. J Med Libr Assoc 2002; 90: 68-75.
43. Ibañez J,Caelles N, Dualde E. Intervention strategies in pharmacotherapy follow-up. Seguim Farmacoter 2003; 1: 82-6.
44. Garavalia LS, Marken PA, Sommi RW. Selecting appropriate assessment methods: asking the right questions. Am J Pharm Educ 2002; 66:108-12.
45. Machuca M, Martinez- Romero F, Faus MJ. Medical-pharmaceutical report according to the Dader methodology for the follow- up of drug treatment. Pharm Care Esp 2000; 2: 358-63.
46. Rossing C, Hansen EH, Krass I, Traulsen JM. Pharmaceutical Care in Denmark: perceived importance of medicine-related problems and participation in postgraduate training. Pharm World Sci 2003; 25: 73-8.
47. Sturgess IK, McElnay JC, Hugues CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 2003; 25: 218-26.
48. Strand LM, Cipolle RJ, Morley PC. Documenting the clinical pharmacist's activities: back to basics. Drug Intell Clin Pharm 1988; 22: 63-7.
49. Currie JD, Doucette WR, Kuhle J, Sobotka J, Miller WA, McDonough RP, et al. Identification of essential elements in the documentation of pharmacist-provided care. J Am Pharm Assoc 2003; 43: 41-7.
50. Aguas Y, De Miguel E, Suarez de Venegas C. Case presentation pattern adapted to Dader Methodology. Pharm Care Esp 2002; 4:60-3.
51. Machuca MP, Oñate MB, Gutierrez- Aranda L, Romero- Barba L, Gastelurrutia P, Machuca M. Clinical sessions in pharmacotherapy follow- up by Dader Method: proposal of a model. Seguim Farmacoter 2003; 1: 69-72.
52. Berger BA. Building an effective therapeutic alliance: competence, trustworthiness and caring. Am J Hosp Pharm 1994; 51: 1824-5.
53. Schomer JC. Pharmacists'new communicative role: explaining illness and medicine to patients. In Explaining Illness: Research, Theory and Strategies. Brian Whaley ed. Lawrence Arlbaum Associatees, Inc NY, 1999; pp. 209-33.
54. Wiederholt JB, Clarridge BR, Svarstad BL. Verbal consultation regarding precription drugs: findings from a statewide study. Med Care 1992; 30: 159-73.
55. Chewning B, Schommer JC. Increasing clients' knowledge of community pharmacists' roles. Pharm Res 1996; 13: 1299-304.
56. Schomer JC, Wiederholt JB. The association of prescription status, patient age, patient gender, and patient questions asking behavior with the content of pharmacists-patient communication. Pharm Res 1997; 14:145-51.
57. Schomer JC, Wiederholt JB. A field investigation of participant and environment effects on pharmacist-patients communication in community pharmacies. Med Care 1995; 33: 567-84.
58. Ferguson WJ, Candib LM. Culture, language, and the doctor-patient relationship. Fam Med 2002; 34: 353-61.
59. Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc 2004; 44: 22-9.
60. Alkhawajah AM, Eferakeya AE. The role of pharmacists in patients' education on medication. Public Health 1992; 106: 231-7.
61. Rainer SB, Daughtridge R, Sloane PD. Physician-patient communication in the primary care office: a systematic review. J Am Board Fam Pract 2002; 15: 25-38.
62. Gouveia WA, Chapman MM. The outcomes of patient care. Am J Health Sys Pharm 1995; 52: S11-5.
63. Ijben G, van Mil JW, Tromp TF, de Jong van den Berg LT. Quantification of communication processes, is it possible?. Pham World Sci 1999; 21: 195-9.
64. Hargie ODW, Morrow NC, Woodman C. Pharmacists' evaluation of key communication skills in practice. Patient Educ Coun 2000; 39: 61-70.
65. O'Neil CK, Poirer TI. Impact of patient knowledge, patient-pharmacists relationships, and drug perceptions on adverse drug therapy outcomes. Pharmacotherapy 1998; 18: 333-40.
66. Skoglund P, Isacson D, Kjellgren KI. Analgesic medication-communication at pharmacists. Patient Educ Couns 2003; 51: 155-61.
67. Berry LL, Selders K, Wilder SS. Innovations in access to care: a patient-centered approach. Ann Intern Med 2003; 139: 568-74.
68. Simon GE, VonKorff M, Rutter C, Wagner E. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ 2000; 320: 550-4.
69. Pinnock H, Bawden R, Proctor S, Wolfe S, Scullion J, Price D, et al. Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trial. BJM 2003; 326: 477-9.
70. Barry HC, Hickner J, Ebell MH, Ettenhofer T. A randomized controlled trial of telephone management of suspected urinary tract infections in women. J Farm Pract 2001; 150: 589-94.
71. Westfall GR and Narducci WA. A community-pharmacy-based callback program for antibiotic therapy. J Am Pharm Assoc 1997; NS37: 330-4.
72. Machuca M, Espejo J, Gutiérrez- Aranda L, Machuca MP, Herrera J. The effect of written information provided by pharmacists on compliance with antibiotherapy. Ars Pharmaceutica 2003; 44:141-57.
73. Morrow D. Improving consultation between health-care professionals and older clients: implications for pharmacists. J Am Pharm Assoc 1999; 39: 835-42.
74. Law AV, Ray MD, Knapp KK, Balesh JK. Unmet needs in the medication use process: perceptions of physicians, pharmacists, and patients. J Am Pharm Assoc 2003; 43: 394-402.
75. Center for the Advancement of Pharmaceutical Education (CAPE) Educational Outcomes, American Association of Colleges of Pharmacy, Alexandria VA, 1998.
76. Accreditation Standars and Guidelines for the Profesional Program in Pharmacy Leading to the Doctor of Pharmacy Degree. American Council in Pharmaceutical Education, Chicago IL, 1997.
77. International Pharmaceutical Federation. FIP Statement of policy. Good pharmacy education practice. Viena, 2000.
78. Tromp FJ. Informe del Grupo de Trabajo para implementar la Atención Farmaceutica en el curriculum. Pharm Care Esp 1999; 1: 270-8
79. Lee MWL, Andritz MH, Curry, CE, Kishi DT, Murray MD, Scott BE, et al. Academic Pharmacy's role in practitioner preparation and continuing development to enhance healthcare and ensure optimal medication use. Report of the 2001-2002 Professional Affairs Committee. Am J Pharm Educ 2002; 66: 23S-7S.
80. Beardsley RS. Communication skills development in Colleges of Pharmacy. Am J Pharm Educ 2001; 65: 307-13.
81. Kuo GM, Buckley TE, Fitzsimmons DS, Steinhauer JR. Collaborative drug therapy management services and reimbursement in a family medicine clinic. Am J Health Syst Pharm. 2004; 61: 343-54.
82. Muijrers PE, Knottnerus JA, Sijbrandij J, Janknegt R, Grol RP. Changing relationships: attitudes and opinions of general practitioners and pharmacists regarding the role of the community pharmacist. Pharm World Sci 2003; 25: 235-41.
83. Ranelli PL, Biss J. Physicians' perceptions of communication with and responsibilities of pharmacists. J Am Pharm Assoc 2000; 40: 625-30.
84. Klopfer JD, Einarson TR. Acceptance of pharmacists' suggestions by prescribers: a literature review. Hosp Pharm 1990; 25: 830-2; 834-6.
85. Liddell MJ, Goldman SP. Attitudes to and use of a modified prescription form by general practitioners and pharmacists. Med J Aust 1998; 168: 322-5.
86. Howard M, Trim K, Woodward C, Dolovich L, Sellors C, Kaczorowski J, et al. Collaboration between community pharmacists and family physicians: lessons learned from the Seniors Medication Assessment Research Trial. J Am Pharm Assoc 2003; 43: 566-72.
87. Fernandez-Llimós F. Dader Program on drug- therapy follow- up: three years. Pharm Care Esp 2003; 5 (Suppl): 35.
88. World Medical Association Statement on the Working Relationship between Physicians and Pharmacists in Medicinal Therapy. Adopted by the 51st World Medical Assembly Tel Aviv, Israel, October 1999. http://www.wma.net/e/policy/m33.htm (accessed 03/01/2004).
89. American College of Physicians-American Society of Internal Medicine. Pharmacy Scope of Practice. Ann Intern Med 2002; 136: 79-85.
90. Canadian Medical Association - Canadian Pharmaceutical Association. Joint Statement. Approaches to enhancing the quality of drug therapy. Can Med Assoc J. September 1996; 155: 784.
91. Ambler S. General practitioners and community pharmacists: times they are a-changing. Br J Gen Pract. 2003; 53: 594-55.
92. Wertheimer AI, Séller A. Preparing the pharmacists for the future: PCT to the rescue. Pharm World Sci 2003; 25: 39.
93. Hepler CD. Practice and pharmaceutical education for 2010. Farm Clin 1997; 114: 127-46.
94. Commission to Implement Changes in Pharmaceutical Education. Entry level education in pharmacy, a commitment to change. In: Penna RP ed. The Papers of the Commission to Implement Change in Pharmaceutical Education. Alexandria, VA: American Association of Colleges of Pharmacy 1994; pp. 35-58.
95. Commission to Implement Changes in Pharmaceutical Education. The responsibility of pharmaceutical education for scholarships, graduate education, fellowships and postgraduate professional education and training. In: Penna RP ed. The Papers of the Commission to Implement Change in Pharmaceutical Education Alexandria, VA: American Association of Colleges of Pharmacy 1994; pp. 59-97.
96. Cipolle RJ, Strand LM, Morley PC. Preparing the pharmaceutical care practitioner. In: Cipolle RJ, Strand LM and Morley PC eds. Pharmaceutical care practice. Mc Graw-Hill, New York 1998; pp. 297-323.
97. Perrier DG, Winsdale N, Pugsley J, Lavack L, Strand LM. Designing a pharmaceutical care curriculum. Am J Pharm Educ 1995; 59: 113-25.
98. Speedie MK, Oslund CA. Curriculum development sets course for student's education. Pharm Record 1998; 10: 6.
99. Isetts BJ. Evaluation of pharmacy students abilities to provide pharmaceutical care. Am J Pharm Educ 1999; 63: 11-20.
100. Grainger-Rousseau TJ, Miralles MA, Hepler CD, Segal R, Doty RE, Ben-Joseph R. Therapeutic outcomes monitoring: application of pharmaceutical care guidelines to community pharmacy. J Am Pharm Assoc 1997; NS37: 647-61.
101. Robertson KE. Process for preventing or identifying and resolving problems in drug therapy. Am J Health Syst Pharm 1996; 53: 639-50.
102. Kennedy DT, Ruffin DM, Goode JV, Small RE. The role of academia in community-based pharmaceutical care. Pharmacotherapy 1997; 17: 1352-6.
103. Bigg J. Teaching for Quality Learning at the University, Society for Research in Higgher Education, Buckingham, England 1999.
104. Raman-Wilms L. Innovative enabling strategies in self-directed, problem-based therapeutics: enhancing student preparedness for pharmaceutical care practice. Am J Pharm Educ 2001; 65: 56-64.
105. Mobach MP, van der Werf JJ, Tromp TF. APOM-project: a survey of pharmacy organization and management. Pharm World Sci 1998; 20: 248-52.
106. Mobach MP, van der Werf JJ, Tromp TF. APOM-project: managing changing to the customer in community pharmacy practice. Pharm World Sci 1999; 21: 205-9.
107. Kubitz C. Introduction to Pharmaceutical Care. Martin-Luther Universität, Wittenberg. http://www.pharmazie.uni-halle.de/sp/intropharmcare.html (accessed 02/02/2004).
108. Herrera J. Pharmaceutical Care education: University of Seville. El Farmacéutico 2002; 282: 76-80.
109. Sorbonne Joint Declaration. Joint declaration on harmonisation of the architecture of the European higer education system. Paris, May 25th, 1998 http://www.bologna-berlin2003.de/pdf/Sorbonne_declaration.pdf (accessed 09/03/2004).
110. Joint Declaration of the European Ministres of Education. The Bologna Declaration on June 19th 1999. From http://www.univ.mecd.es/univ/jsp/ (accessed 04/03/2004).
111. Meeting of European Ministres in Charges of Higher Education. The Prague Declaration on May 19th 2001. From http://www.univ.mecd.es/univ/jsp/ (accessed 04/03/2004).
112. Communication of the Conference of Ministres resposibles for Higher Education. Realising the Europea Higher Education Area. Berlin, September 19th, 2003. From http://www.univ.mecd.es/univ/jsp/ (accessed 04/03/2004).
113. Ruíz I, Jirón M, Pinilla E, Paulos C, Pezzani M, Rubio B, et al. Pharmaceutical care education at the University of Chile. Am J Pharm Educ 2002; 66: 144-7.
114. Bertoldo P, Huespe C, Ascar G, Welter A, Mainardi C. Pharmaceutical health care education by application of tutorial teaching. Pharm Care Esp 2003; 5: 170-2.
115. Martínez-Sánchez, AM. Pharmaceutical Care: a challenge to curricula design in Pharmacy careers. Pharm Care Esp 2003; 5: 94-7.
116. Fuhrman LC Jr., Buff WE, Eaddy M, Dollar M. Utilization of an integrated interactive virtual patient database in a web-based environment for teaching continuity of care. Am J Pharm Educ 2001; 65: 271-5.
117. PCNE, http://www.pcne.org/ (accessed 04/03/2004).
118. Winsdale NE, Strand LM, Pugsley JA, Perrier DG. Practice functions necessary for the delivery of pharmaceutical care. Pharmacotherapy 1996; 16: 889-98.
119. Barner JC, Bennett RW. Pharmaceutical care certificate program: Assessment of pharmacists implementation into practice. J Am Pharm Ass 1999, 39: 362-7.
120. Young MD, Stilling WJ, Munger MA. Pharmacy practice acts: A decade of progress. Ann Pharmacother 1999; 33: 920-6.
121. Farris KB, Kassam R, Cox CE, Volume CI, Cave A, Schopflocher DP, et al. Evaluation of a practice enhancement program to implement pharmaceutical care. Am J Pharm Educ 1999; 63: 277-84.
122. ACPE. Accreditation Standars and Guidelines for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree. The American Council on Pharmaceutical Education Inc, Chicago IL, 1997.
123. Posey LM. Proving that pharmaceutical care makes a difference in community pharmacy. Viewpoint. J Am Pharm Assoc 2003; 43: 136-9.
124. Farris KB, Schopfloecher DP. Between the intention and behavior: an application of community pharmacists' assessment of pharmaceutical care. Soc Sci Med 1999; 49: 55-6.
125. Tice B. Pharmaceutcial care: a necessary "disruptive innovation" in health care. J Am Pharm Assoc 2002; 42: 381-2.
126. Weidle P, Bradley L, Gallina J. Pharmaceutical Care Intervention Documentation Program and Related Cost Savings at a University Hospital. Hosp Pharm 1998; 34: 43-52.
127. Smythe M, Shah P, Spiteri T. Pharmaceutical Care in Medical Progressive Care Patients. Ann Pharmacother 1998; 32: 294-9.
128. Comer J. Documenting pharmacist's interventions. Am J Hosp Pharm 1985; 42: 625-6.
129. Wang J, Muller R, Lucarrelli CH. A Pharmacy Intervention Program: Recognizing pharmacy's contribution to improving Patient Care. Hosp Pharm 1995; 30: 123-6.
130. Mutnick A, Sterba K. Cost savings and avoidance from clinical interventions. Am J Health-Syst Pharm 1997; 54: 392-60.
131. Laksmanan M, Hershey C, Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med 1986; 146: 1931-4.
132. Bermúdez-Tamayo C, Silva- Castro MM, Martín Martín J, Márquez Calderón S, Calleja MA, Faus MJ. Evaluación económica de la Atención Farmacé utica en el ámbito hospitalario. Seguim Farmacoter 2004 (in press).
133. Carter BL, Malone DC, Valuck RJ, Barnette DJ, Sintek CD, Billups SJ. The IMPROVE study: background and study design. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Am J Health Syst Pharm 1998; 55: 62-7.
134. Ellis SL, Billups SJ, Malone DC, Carter BL, Covey D, Mason B et al. Types of intervention made by clinical pharmacists in the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000; 20: 429-35.
135. Tomechko MA, Strand LM, Morley PC, Cipolle RJ. Q and A from the pharmaceutical care project in Minnesota. Am Pharm 1995; NS35: 30-9.
136. Cipolle RJ, Strand LM, Morley PC, Frakes M. Pharmaceutical Care Practice: The Clinician's Guide (In press).
137. Michigan Pharmaceutical Care Project. Available from: URL: www.mipharm.com/pharm∥of/MichiganPharmaceuticalCareModel.pdf (accessed 02/16/2004).
138. Principles of Practice for Pharmaceutical Care. Avalaible from: URL: www.aphanet.org/pharmcare/prinprac.html. (accessed 01/28/2004).
139. Odenina FT, Hepler CD, Segal R, Miller D. The Pharmacists' Implementation of Pharmaceutical Care (PICP) model. Pharm Res 1997; 14:135-44.
140. Kassam R, Farris KB, Cox CE, Volume CI, Cave A, Schopflocher DP, et al. Tools used to help community pharmacists implement comprehensive pharmaceutical care. J Am Pharm Assoc 1999; 39: 843-56.
141. Dunlop JA, Shaw JP. Community pharmacist's perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci 2002; 24: 224-30.
142. Foppe van Mill JW, Tromp DF, McElnay JC, de Jong-van den Berg LT, Vos R. Development of pharmaceutical care in The Netherlands: pharmacy's contemporary focus on the patient. J Am Pharm Assoc 1999; 39: 395-401.
143. Rossing C, Hansen EH, Krass I. The provision of pharmaceutical care in Denmark: a cross- sectional survey. J Clin Pharm Ther 2003; 28: 311-8.
144. Berguillos L, López I, Zardain E, Comas R. Factibilidad de implantación de un modelo de dispensación activa de medicamentos con receta en oficinas de farmacia asturianas. Estudio piloto. Pharm Care Esp 2003; 5: 247-252
145. Machuca M, Oñate MB, Romero-Barba L, Gutiérrez-Aranda L, Machuca MP. Propuesta de modelo de actuación en indicación farmacéutica adaptado al consenso español en atención farmacéutica. Seguim Farmacoter 2003; 1: 141-146.
146. Fernández Llimós F. Programa Dader de seguimiento farmacoterapéutico: tres años de resultados. Pharm Care Esp 2003; 5: 34-41.
147. Smith CP, Christensen DB. Identification and clarification of drug therapy problems by Indian health service pharmacists. Ann Pharmacother 1996; 30:119-24.
148. Oddis JA. Future practice roles in pharmacy. Am J Hosp Pharm 1988; 45: 1306-10.
149. Desselle S, Hunter TS. The evolution of Parmaceutical Care into Managed Care Environments. J Managed Care Pharm 1998; 4: 55-8.
150. Plaza L, Herrera J. The new challenge in Pharmaceutical Health Care: to reach a consensus among the professionals. Pharm Care Esp 2003; 5: 160-5.
151. Low J. Pharmaceutical Care: an overview. Aus J Hosp Pharm 1996; 26: 32-3.
152. Lloyd A. PSA Pharmaceutical Care Projet. Aus J Hosp Pharm 1996; 26: 34-5.
153. Farris KB, Kumbera P, Halterman T, Fang G. Outcomes- based pharmacist reimbursement: reimbursing pharmacists for cognitive services (part 1). J Managed Care Pharm 2002; 8: 383-93.
154. Norwood GJ, Sleath BL, Caiola SM, Lien T. Costs of implementing Pharmaceutical Care in community pharmacies. J Am Pharm Assoc 1998; 38: 755-61.
155. Young MD, Stilling WJ, Munger MA. Pharmacy practice acts: a decade of progress. Ann Pharmacother 1999; 33: 920-6.
156. Berger BA, Grimley D. Pharmacist's readiness for rendering pharmaceutical care. J Am Pharm Assoc 1997; NS37: 535-542.
157. Barner JC, Bennett RW. Pharmaceutical care certificate program: assessment of pharmacists' implementation into practice. J Am Pharm Assoc 1999; 39: 362-7.
158. MacKeigan LD, Marshman JA, Kruk-Romanus D, Milovanovic DA, Jackevicius C, Naglie G, et al. Clinical pharmacy services in the home: Canadian case studies. J Am Pharm Assoc 2002; 42: 735-42.
159. Desselle S. Pharmacists' perceptions of a set of pharmaceutical care practice standards. J Am Pharm Assoc 1997; NS37:529-34.
160. Glover C. The future of the profession. The Pharma J 2000; 264:13-4.
161. Plaza F. Pharmaceutical Care. Actual state and pharmaceutic service's development: reasons for the change. Pharm Care Esp 1999; 1: 48-51.
162. Bradshaw SJ, Doucette WR. Community pharmacists as patient advocates: physician attitudes. J Am Pharm Assoc. 1998; 38: 598-602.
163. Haxby DG, Weart CW, Goodman BW Jr. Family practice physicians' perceptions of the usefulness of drug therapy recommendations from clinical pharmacists. Am J Hosp Pharm 1988; 45: 824-7.
164. Spencer JA, Edwards C. Pharmacy beyond the dispensary: general practitioners' views. BMJ 1992; 304: 1670-2.
165. Zermansky AG, Petty DR, Raynor DK, Feemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323: 1-5.
166. Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003; 169: 17-22.
167. Campbell RK, Saulie BA. Providing pharmaceutical care in a physician office. J Am Pharm Assoc 1998; 38: 495-9.
168. Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, et al. Effectiveness of Pharmacist Care for patients with Reactive Airways Disease. A Randomized Controlled Trial. JAMA 2002; 288: 1594-1602.
169. Hepler CD, Strand LM, Tromp D, Sakolchai S. Critically examining pharmaceutical care. J Am Pharm Assoc 2002; 42: S18-9.
170. Singhal PK, Raisch DW, Gupchup GV. The impact of Pharmaceutical Services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother 1999; 33:1336-55.
171. Tully MP, Seston EM. Impact of pharmacists providing a prescription review and monitoring service in Ambulatory Care or Community Practice. Ann Pharmacother 2000; 34:1320-31.
172. Machuca M. On the necessity of investigation in the community pharmacy[editorial]. Pharm Care Esp 2000; 2: 307-9.
173. Vivian EM. Improving Blood Pressure Control in a Pharmacist-Managed Hypertension Clinic. Pharmacotherapy 2002; 22: 1533-40.
174. Cranor CW, Bunting BA, Christensens DB. The Ashville Project: Long- term clinical and economic outcomes of a community pharmacy diabetes program. J Am Pharm Assoc 2003; 43:173-84.
175. Bourinbaiar AS, Jirathitikal V. Low-cost anti-HIV compounds: potential application for AIDS therapy in developing countries. Curr Pharm Design 2003; 9(18): 1419-31.
176. Sahm DF, Thornsberry C, Karlowsky JA. The application of information technology to regional, national, and global surveillance of antimicrobial resistance. Curr Pharm Design 2003; 9(12): 969-74.
177. van Drie JH. Pharmacophore discovery-lessons learned. Curr Pharm Design 2003; 9(20): 1649-64.